Health
Pfizer expects to cut COVID-19 vaccine production time by close to 50% as production ramps up, efficiencies increase – USA TODAY
As the nation revs up its vaccination programs, the increase could help relieve bottlenecks caused by vaccine shortages.
New research suggests the COVID-19 vaccine made by Pfizer and BioNTech can still work against a mutated coronavirus. Two easier-to-spread new variants of the virus have the world on edge. One was first discovered in Britain and South Africa. (Jan 8)
AP Domestic
Pfizer expects to nearly cut in half the amount of time it takes to produce a batch of COVID-19 vaccine, from 110 days to an average of 60, as it makes the process more efficient and production is built out, the company told USA TODAY.
As…
-
Noosa News17 hours agoMeet Chad Burgess, Pauline Hanson’s One Nation Party
-
Noosa News24 hours agoScenic Rim council cracks down on farmers hosting campers without a permit
-
Noosa News18 hours agoWestern Queensland graziers begin grim stock count after catastrophic floods
-
Noosa News20 hours agoFrom Dreamy Dining Rooms to Moody Basement Bars, Nearly 200 Venues Have Been Shortlisted for the 2025 Australian Interior Design Awards